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Gas6 Inhibits Toll-Like
Receptor-Mediated Inflammatory
Pathways in Mouse Microglia via Axl
and Mer
Shannon E. Gilchrist, Salman Goudarzi and Sassan Hafizi*
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
Background: Microglia are well known key regulators of neuroinflammation which
feature in multiple neurodegenerative disorders. These cells survey the CNS and, under
inflammatory conditions, become “activated” through stimulation of toll-like receptors
(TLRs), resulting in changes in morphology and production and release of cytokines. In
the present study, we examined the roles of the related TAM receptors, Mer and Axl, and
of their ligand, Gas6, in the regulation of microglial pro-inflammatory TNF-α production
and microglial morphology.
Methods: Primary cultures of murine microglia of wild-type (WT), Mer−/− and Axl−/−
backgrounds were stimulated by the TLR4 agonist, lipopolysaccharide (LPS) with or
without pre-treatment with Gas6. Gene expression of TNF-α, Mer, and Axl was examined
using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and
enzyme-linked immunosorbent assay (ELISA) was used to measure TNF-α release from
microglia. Immunofluorescence staining of β-actin and the microglial marker Iba1 was
performed to reveal microglial morphological changes, with cellular characteristics
(area, perimeter, Feret’s diameter, minimum Feret, roundness, and aspect ratio) being
quantified using ImageJ software.
Results: Under basal conditions, TNF-α gene expression was significantly lower in
Axl−/− microglia compared to WT cells. However, all microglial cultures robustly
responded to LPS stimulation with the upregulation of TNF-α expression to similar
degrees. Furthermore, Mer receptor expression was less responsive to LPS stimulation
when in Axl knockout cells. The presence of Gas6 consistently inhibited the LPS-induced
upregulation of TNF-α in WT, Mer−/− and Axl−/− microglia. Moreover, Gas6 also inhibited
LPS-induced changes in the microglial area, perimeter length, and cell roundness in
wild-type cells.
Abbreviations: ANOVA, analysis of variance; B&W, black and white; BSA, bovine serum albumin; CST, Cell Signaling
Technologies; DAMPs, damage-associated molecular patterns; DMEM, Dulbecco’s modified eagle medium; ELISA,
enzyme-linked immunosorbent assay; FBS, fetal bovine serum; HS, horse serum; LPS, lipopolysaccharide; NT, no
treatment; P/S, penicillin/streptomycin; PAMPs, pathogen-associated molecular patterns; PFA, paraformaldehyde; PPRs,
pattern recognition receptors; qPCR, quantitative polymerase chain reaction; RT, reverse transcription; RTKs, receptor
tyrosine kinases; TLRs, Toll-like receptors; WT, wild-type.
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Conclusion: Gas6 can negatively regulate the microglial pro-inflammatory response
to LPS as well as via stimulation of other TLRs, acting through either of the TAM
receptors, Axl and Mer. This finding indicates an interaction between TLR and TAM
receptor signaling pathways and reveals an anti-inflammatory role for the TAM ligand,
Gas6, which could have therapeutic potential.
Keywords: microglia, Gas6, TAM receptors, toll-like receptors, LPS, inflammation, TNF-α, primary cell culture
BACKGROUND
Neuroinflammation is a common feature of disorders such
as multiple sclerosis or Alzheimer’s disease, among others,
occurring at various stages of disease progression (Weggen et al.,
2001; Frischer et al., 2009; Heneka et al., 2014; Dendrou et al.,
2015). Microglia, the principal immune cells of the CNS, are
responsible for surveying the CNS environment in search of
damage (Nimmerjahn et al., 2005; Salter and Stevens, 2017).
Upon activation, microglia can detect a variety of stimuli through
detecting damage- or pathogen-associated molecular patterns
(DAMPs or PAMPs, respectively) and respond by creating an
inflammatory milieu through the release of cytokines such as
TNF-α and IL-1β (Lively and Schlichter, 2018; Subedi et al.,
2019). In inflamed tissue, microglia can control the release of
pro-inflammatory cytokines, switching to an anti-inflammatory
response to promote healing (Heneka et al., 2014). Moreover,
microglia undergo morphological changes upon inflammatory
stimulation. The transition from their surveillant state to a more
‘‘classically’’ activated phenotype has been well characterized
with cells switching from a ramified, extended morphology to
a more rounded, amoeboid structure (Djukic et al., 2006; Tam
and Ma, 2014; Michell-Robinson et al., 2015; Arcuri et al., 2017).
It is this molecular and phenotypic regulation of microglia that
may become inefficient during neurodegeneration as chronic
inflammation takes hold (Song and Colonna, 2018).
Toll-like receptors (TLRs) are a family of pattern recognition
receptors (PRRs), present on the surface of microglia (Bsibsi
et al., 2002; Olson and Miller, 2004; Frederiksen et al., 2019).
TLR4, for which the gram-negative bacterial cell wall component
lipopolysaccharide (LPS) is a strong agonist, is well known
for its role in inflammation, providing many opportunities
for therapeutics (Jack et al., 2005; Lu et al., 2008; Roy et al.,
2016). The TAM (Tyro3, Axl, Mer) subfamily of receptor
tyrosine kinases (RTKs) are known to play an important role
in the resolution of inflammation, both within and outside
the CNS (Lemke and Rothlin, 2008; Shafit-Zagardo et al.,
2018; Lee and Chun, 2019). For example, Mer−/− mice treated
with LPS show an exacerbated sickness behavior (Camenisch
et al., 1999). Furthermore, TAM receptors, along with their
ligand Gas6, have been implicated in the negative regulation
of pro-inflammatory cytokine release from LPS-stimulated cells
(Binder et al., 2008; Alciato et al., 2010).
Within the CNS, TAM receptor expression is highly variable
concerning both age and cell type. Microglia have a strong
expression of both Axl and Mer receptors but a negligible
expression of Tyro3, especially neonatally (Prieto et al., 2000;
Shafit-Zagardo et al., 2018; Goudarzi et al., 2020). Although
Axl and Mer, along with Gas6, are known to play important
roles in the macrophage/microglial inflammatory response, little
has been confirmed regarding the specific roles that each
receptor plays in the resolution of the response, nor their
actions on microglial morphological responses. Therefore, this
study aimed to investigate the specific roles of the TAM
receptors, Mer and Axl, in regulating TNF-α expression and
release in primary mouse microglia as well as to explore the
impact of Gas6 on microglial morphological changes under
pro-inflammatory conditions. Here, we have used single receptor
knockout microglia to study both cytokine release in response
to pro-inflammatory stimulation and morphological effects, with
and without the influence of ligand stimulation by Gas6. We
discovered that both Mer and Axl play important roles in
inflammatory resolution and that Gas6 can inhibit a broad range
of TLR-mediated inflammatory induction of TNF-α as well as
associated morphological changes.
MATERIALS AND METHODS
Primary Mouse Microglial Cell Cultures
All experimental procedures were performed following the
Animals (Scientific Procedures) Act, 1986 under a UK Home
Office project license (license number PC2238199) with approval
from the institutional ethics committee (AWERB).
Primary microglial cells were derived according to Mecha
et al. (2011). In brief, cells were isolated from neonatal
(P1–3) wild-type (WT; C57/BL6), Mer mutant (Mer−/−; Jackson
Laboratories, Bar Harbor, ME, USA), and Axl mutant (Axl−/−;
Jackson Laboratories) mouse brains and cultured in Dulbecco’s
Modified Eagle Medium (DMEM; Thermo Fisher Scientific,
Loughborough, UK) supplemented with 10% fetal bovine serum
(FBS; Lonza, Slough, UK), 10% horse serum (HS; Gibco
Invitrogen, Paisley, UK) and 1% penicillin/streptomycin (P/S;
Thermo Fisher Scientific) at 37◦C for 10–14 days. Cultures
were then shaken orbitally at 260 rpm for 3 h to detach the
microglia, which were seeded onto poly-D-lysine coated 24-well
plates at a cell density of 3 × 105 cells/well for protein/RNA
extraction protocols or onto coverslips (circular, 16 mm
diameter; Thermo Fisher Scientific) at 4 × 104 cell density for
immunofluorescence staining.
Cells were allowed to adhere for 1–2 days before the medium
was changed to DMEM containing 1% FBS and 1% P/S into
which treatments were added. Pro-inflammatory stimulation was
induced by adding LPS (10 ng/ml; Sigma–Aldrich, Gillingham,
UK) to cells. Other cell treatments included the TAM receptor
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ligand, Gas6 (1.6 µg/ml; produced in house as detailed in
Stenhoff et al., 2004).
RNA Extraction, Reverse Transcription,
and qPCR
After experimental treatments, media was removed from wells,
and cells were lysed for total RNA extraction and purification
using the RNeasyMini Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. RNA concentration and
purity were measured using a spectrophotometer (ND-1000;
NanoDrop Technologies, Wilmington, DE, USA). Equal
amounts of total RNA were reverse transcribed (RT) into
cDNA (High Capacity cDNA Reverse Transcription Kit,
Applied Biosystems, Foster City, CA, USA) which was used
to perform quantitative polymerase chain reaction (qPCR)
using gene-specific primer/fluorescent hydrolysis probe sets
(Integrated DNA Technologies, IDT, Leuven, Belgium). Gene
expression was normalized to Gapdh (Thermo Fisher Scientific)
as a reference gene in each sample; relative gene expression
was calculated using 2−∆Ct and fold change in expression was
calculated using 2−∆∆Ct for different experiments, as previously
described (Schmittgen and Livak, 2008).
Enzyme-Linked Immunosorbent Assay
(ELISA)
Legend MaxTM Mouse TNF-α Enzyme-Linked Immunosorbent
Assay (ELISA) Kit (BioLegend, San Diego, CA, USA) was used
following the manufacturer’s instructions to measure protein
levels in cell-conditioned media. In brief, the medium was
added to a 96-well plate pre-coated with hamster monoclonal
anti-mouse TNF-α capture antibody. After incubation at room
temperature for 2 h, samples were washed and the detection
antibody was added for a further hour. After further washing,
avidin-horseradish peroxidase was used for detection and optical
density was measured at 450 nm and 570 nm (Multiskan GO;
Thermo Fisher Scientific).
Immunofluorescence Staining
After treatments, media was removed from coverslips by
aspiration, and cells were washed twice with PBS, then fixed by
incubation with 4% paraformaldehyde (PFA; Sigma–Aldrich) in
PBS for 10 min at room temperature. Cells were then washed
in PBS (3 × 5 min) before permeabilization with 0.3% Triton
X-100 at room temperature for 5 min. Coverslips were washed
again (3 × 5 min) before further permeabilization using 100%
methanol at −20◦C for 10 min. After a final wash, cells were
blocked in 5% HS for 1 h.
For staining, coverslips were incubated in primary antibodies
made in 1% bovine serum albumin (BSA) solution to
appropriate dilutions at 4◦C overnight. Primary antibodies were
removed, coverslips were washed and secondary antibodies
in 1% BSA were added for 1 h at room temperature.
Coverslips underwent a final wash in PBS before being
mounted onto clear glass microscopy slides using PermaFluor
AqueousMountingMedium (Thermo Fisher Scientific). Primary
antibodies used were rabbit anti-Iba1 (1:300; Fujifilm Wako
Pure Chemical Corporation, Japan) and mouse anti-β-actin
[1:2,500; Cell Signaling Technologies (CST), London, UK].
Secondary antibodies used were anti-rabbit AlexaFluor 488
(1:1,000; Invitrogen, UK), anti-mouse Cy3 (1:1,000; Invitrogen),
and the stain DAPI was used at 1:400 (Invitrogen Molecular
Probes). Images were taken on a laser scanning confocal
microscope (Zeiss LSM 710, Cambridge, UK).
Image Processing
The program RBS ImageJ was used for all image processing.
Firstly, all images were scaled to micrometers and converted
to black and white (B&W) images using ‘‘Image. . . Colour
Threshold.’’ Cellular characteristics were then measured using
‘‘Analyze. . .Analyze Particles’’ where numbered outlines were
created for each cell over 100 µm2 that did not cross the
image threshold (Supplementary Figure 1) and parameters were
automatically measured. Parameters used were area, perimeter,
Feret’s diameter, minimum Feret, roundness, and aspect ratio
as described in Zanier et al. (2015). A subtype of giant
multinucleated phagocytic cells (Fendrick et al., 2007; Hornik
et al., 2014) were excluded from data analysis due to the
limited number observed in images. Furthermore, extreme data
outliers and any cells in contact with others were removed from
the analysis. In total, over 300 cells were analyzed for each
treatment group.
Statistical Analysis
Statistical analysis was performed using Prism 8 (GraphPad
Software, San Diego, CA, USA). The normal distribution of
experimental data was determined using the Shapiro–Wilk
test. Statistical tests used on normally distributed data were
one-way analysis of variance (ANOVA) or paired Student’s
t-tests, whereas non-parametric tests used were Kruskal–Wallis,
Friedman’s, or Wilcoxon signed-ranked tests. A p ≤ 0.05 was
considered as statistically significant. Data analyzed were from
a minimum of four independent experiments on separate
primary cultures.
RESULTS
Axl Knockout Microglia Show Reduced
Baseline TNF-α Expression, but Wild-Type
and TAM Knockout Cells Respond Equally
to LPS
To discover the role of Mer and Axl receptors in intrinsic
TNF-α expression in primary microglia, reverse transcription-
quantitative polymerase chain reaction (RT-qPCR) was used to
measure TNF-α gene expression in non-stimulated microglia
of WT, Mer−/− and Axl−/− backgrounds. Under basal
conditions, Axl−/− microglia displayed significantly lower
TNF-α gene expression when compared with WT microglia,
whereas Mer−/− cells displayed no such difference (Figure 1A).
LPS (10 ng/ml) addition to WT microglia for 8 h caused
a massive upregulation of TNF-α gene expression through
TLR4 activation (Roy et al., 2016), which also occurred to
the same degree in both Mer−/− and Axl−/− microglia, all
differing significantly from basal values (Figure 1B). We also
observed this effect with a separate commercial LPS preparation
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FIGURE 1 | Reduced baseline but not an inflammatory-stimulated expression of TNF-α in Mer and Axl deficient microglia. Reverse transcription-quantitative
polymerase chain reaction (RT-qPCR) was used to determine the relative gene expression (2−∆Ct) of TNF-α in wild-type (WT), Mer−/− or Axl−/− microglia when (A)
unstimulated or (B) stimulated with lipopolysaccharide (LPS; 10 ng/ml) for 8 h. Gapdh was used as a reference gene. Data shown are individual data points with a
median bar for n ≥ 6 independent experimental repeats. Statistical significance was determined using Mann-Whitney test comparing Mer−/− or Axl−/− microglia
against WT (∗) or by using Wilcoxon signed-rank tests to compare pairwise differences between basal and lipopolysaccharide (LPS) values (#); ∗p < 0.05; #p < 0.05;
##p < 0.01; ###p < 0.005.
(Supplementary Figure 2), which furthermore showed the TNF-
α-inducing effect occurred mainly via distinct TLRs and not
all equally.
Pro-inflammatory Stimulation by LPS
Downregulates Mer but Upregulates Axl
Expression in Microglia, With Axl Proving
Necessary for This Response
To understand the underlying alterations in TAM receptors
in response to LPS, we measured gene expression of Mer
and Axl receptors first in WT and then Mer−/− and Axl−/−
microglia. In WT microglia, stimulation with LPS (10 ng/ml)
for 8 h caused a significant upregulation of Axl expression
concomitant with a significant downregulation of Mer
(Figure 2A). Interestingly, the LPS-induced upregulation
of Axl was also observed in Mer−/− microglia (Figure 2B)
whilst, in contrast, LPS did not alter Mer expression
in Axl −/− cells (Figure 2C). This response indicates
a potential regulatory role of Axl for the expression of
Mer in microglia. Furthermore, under baseline, non-LPS-
stimulated conditions, single knockout of either Mer or Axl
receptor caused a significant increase in the other remaining
TAM receptor (Supplementary Figure 3; p = 0.0032, Mer
expression for WT vs. Axl−/− baseline; p = 0.0003, Axl
expression for WT vs. Mer−/− baseline). This suggests a
compensation between the TAM receptors when one is
non-functional.
Gas6 Inhibits LPS-Induced TNF-α
Upregulation in Both Wild-Type and
Knockout Microglia
To further distinguish the roles of Mer and Axl receptors,
we primed cells with their ligand, Gas6, before stimulating
cells with LPS and measuring TNF-α expression. Initially, we
confirmed the ability for LPS to almost completely suppress
endogenous Gas6 expression in WT microglia (Supplementary
Figure 4). This would mean that all experiments under LPS
inflammatory conditions using exogenous Gas6 to activate
Mer and Axl would be exclusively through exogenous and
not endogenous Gas6. Under conditions of LPS stimulation,
the presence of Gas6 throughout the 8-h incubation period
(including 1 h preceding it) attenuated the upregulation of
TNF-α gene expression in both WT and single TAM receptor
knockout microglia (Figure 3A). This response occurred in a
pairwise trend with the majority of samples showing a substantial
down-regulation of gene expression (p = 0.4375, WT LPS vs.
LPS + Gas6 vs; p = 0.0625, Mer−/− LPS vs. LPS + Gas6;
p = 0.0625, Axl−/− LPS vs. LPS + Gas6). LPS also strongly
induced the upregulation of TNF-α at the protein level as
measured by ELISA analysis of TNF-α released from cells into
the medium (Figure 3B). However, the Gas6 inhibitory effects
observed by qPCR were not significant at the protein level. Also,
both Axl−/− and Mer−/− cells showed significantly lower levels
of LPS-induced TNF-α protein release thanWT cells (p = 0.0286,
LPS WT vs. LPS Axl−/−; p = 0.0286, LPS WT vs. LPS Mer−/−).
The interference of Gas6 in signaling pathways regulating TNF-α
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 October 2020 | Volume 14 | Article 576650
Gilchrist et al. Gas6 Inhibition of Inflammatory Pathways
FIGURE 2 | LPS stimulation alters TAM receptor expression in opposite directions, with Axl regulating the Mer response. After 8 h LPS (10 ng/ml) stimulation or not,
RT-qPCR was used to determine the relative gene expression (2−∆Ct) of (A) Axl and Mertk in WT microglia, (B) Axl in Mer−/− microglia, and (C) Mertk in Axl−/−
microglia. Gene expression was normalized to Gapdh. Data shown are individual data points with the median line for n ≥ 5 independent experimental repeats.
Statistical significance was determined using Wilcoxon signed-rank test; ∗p < 0.05; ∗∗∗p < 0.001.
expression was not unique to TLR4 activation, as we also
observed the same inhibitory effect of Gas6 downstream of other
TLR agonists (Supplementary Figure 2).
Gas6 Limits Changes in Morphological
Characteristics in Microglia in Response to
LPS Stimulation
LPS is known to activate microglia to anM1 phenotype, resulting
in them becoming more amoeboid in morphology (Tam and
Ma, 2014). Here, we confirmed the LPS-induced transition
to a more rounded morphology and investigated whether the
changes in TNF-α expression observed with Gas6 pre-treatment
also translated into morphological changes. WT microglia were
seeded onto glass coverslips and treated with LPS (10 ng/ml),
with or without 1 h Gas6 (1.6 µg/ml) pre-treatment, for 19 h
(Figure 4). DAPI was used for nuclear staining, Iba1 to confirm
the purity of microglial cultures, and β-actin to visualize the
cytoskeleton and morphology of cells. Data were normalized for
each experimental repeat to account for variation among cultures
(original data and all images in Supplementary Figure 5). LPS
stimulation of microglia had a profound effect on morphology,
measured through several parameters (Figure 4B). Moreover,
Gas6 pre-treatment of LPS-stimulated microglia significantly
reverted the altered morphological parameters area, perimeter,
and roundness towards the non-stimulated state, with cells
displaying a less pronounced amoeboid shape.
DISCUSSION
In the present study, we have shown that the potent
TLR4 agonist, LPS, strongly induced expression of the
pro-inflammatory cytokine TNF-α in mouse microglia, in both
WT cells and those deficient in either the Mer or Axl receptor.
The absence of a single TAM receptor did not influence the
ability of microglia to respond to this major pro-inflammatory
stimulus, although basal TNF-α expression was reduced in
Axl−/− microglia. Interestingly, baseline expression of Mer or
Axl was significantly higher in cells in which the other receptor
was absent as compared to WT cells, suggesting a compensatory
effect. Additionally, we observed that the TAM receptor ligand,
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FIGURE 3 | Gas6 inhibits TNF-α induction by LPS in WT and single TAM receptor knockout microglia. (A) RT-qPCR was used to determine the fold change
(2−∆∆Ct) in TNF-α gene expression in WT, Mer−/− or Axl−/− microglia following 8 h of LPS (10 ng/ml) stimulation with or without 1 h pre-treatment with Gas6
(1.6 µg/ml); fold-change in expression for each experimental repeat (n = 5) is displayed. (B) Enzyme-Linked Immunosorbent Assay (ELISA) measurement of TNF-α
protein in culture media under the same experimental conditions as in panel (A), with individual data points from each separate culture and median bar displayed for
n = 4 independent experimental repeats. Statistical tests used were (A) Wilcoxon signed-rank tests or (B) Friedman’s tests; ∗p < 0.05.
Gas6, had an inhibitory effect on LPS-induced microglial
TNF-α expression and release, independently of Mer or Axl
receptor knockout. Finally, we observed significant alteration
of microglial morphology in WT microglia in response to LPS
which was also counteracted by Gas6.
The TAM receptor system is well established in immune
processes, evident from the increased susceptibility of Mer−/−
mice to LPS-induced inflammation (Camenisch et al., 1999)
and TAM receptor triple knockout mice displaying autoimmune
characteristics (Lu and Lemke, 2001). The effects of TAM
receptors on pro-inflammatory responses are often identified
through alterations in cytokine expression or changes to
intracellular signaling pathways (Rothlin et al., 2007; Ji et al.,
2013; Zheng et al., 2015). In keeping with our observations,
other studies have also reported the ability of individual TAM
receptors to work in concert when regulating the cell’s response
to stimuli. For example, Axl and Mer have been shown to
work together for optimal clearance of apoptotic cell bodies by
microglia (Fourgeaud et al., 2016), and phagocytosis by bone
marrow-derived macrophages is dependent on both Mer and
Axl kinase activity (Zagórska et al., 2014). Also, recent evidence
supports the independent roles of Mer and Axl, whilst working
together to suppress inflammatory responses (Zagórska et al.,
2020). Furthermore, opposite responses of Mer and Axl to
inflammatory conditions have been reported in human myeloid
cells (Healy et al., 2016), with the upregulation of Axl being
associated with a pro-inflammatory response (Gao et al., 2019).
The present study in microglia also concurs with previous
reports of the negative regulatory role of Gas6 in inflammatory
signaling in other cells. For example, Gas6 has previously
been shown to have a suppressive effect on TLR-mediated
pro-inflammatory cytokine production in cardiomyocytes
(Grommes et al., 2008), microglial cell lines (Li et al., 2019),
mouse macrophages (Deng et al., 2011) and primary murine
microglia (Binder et al., 2008). There is growing evidence linking
alleviation of inflammation to morphological alterations in
microglia which are associated with pro-inflammatory signaling
responses and cytokine expression (Zhang et al., 2014, 2019;
Kalakh and Mouihate, 2017; Honjoh et al., 2019). This study
used WT microglia to observe the potential modulatory effects
of Gas6 on microglial morphological characteristics. We did
not analyze morphology in TAM single knockout cells as their
TNF-α release profiles under LPS conditions were similar
to wild-type responses, as were the Gas6 effects on these;
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FIGURE 4 | Gas6 counteracts LPS-induced changes in microglial morphology. (A) Representative images of primary microglial cultures treated with LPS (10 ng/ml
for 19 h) with or without 1 h pre-treatment with Gas6 (1.6 µg/ml). Cells were stained with DAPI, Iba1, and β-actin and imaged under fluorescence confocal
microscopy. Scale bar −100 µm. Arrowheads indicate a multinucleated cell. (B) Quantification of morphological characteristics (area, Feret’s diameter, roundness,
perimeter, minimum Feret, and aspect ratio) for n = 4 individual experimental repeats (n > 300 cells per treatment group). Data normalized to the control no treatment
(NT) group is displayed as fold change on violin plots showing median and upper/lower quartiles. Statistical tests used were one-way analysis of variance (ANOVA)
with Tukey post hoc analysis; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
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therefore, the morphological responses would be expected to be
the same.
When measuring TNF-α protein release, the data concurred
with the gene expression analysis in some areas but not others.
For example, there were no significant differences between the
LPS-induced TNF-α gene expression between the three groups
of cell cultures, whereas under LPS stimulation, Mer−/− and
Axl−/− cells showed lower TNF-α protein release than WT cells.
This could be due to amaximal activation by LPS of theTnfa gene
promoter that is too strong to be affected by the lack of a single
TAM receptor. In contrast, TNF-α protein release occurs at the
end of a multi-level pathway to expression and therefore could
be more sensitive to the absence of a TAM receptor through
post-transcriptional mechanisms such as protein modification,
stability, or trafficking (Vogel and Marcotte, 2012). Also, the
lack of difference between baseline TNF-α protein release byWT
and Mer−/−/Axl−/− cells could be due to the poorer sensitivity
of ELISAs for the detection of low levels of cytokine present
in the supernatant, not taking into account cytokines that had
been consumed by cells (Amsen et al., 2009). Also, we observed
that active stimulation of either the TAM receptor by Gas6 is
capable of suppressing the LPS effect at the gene level but not
significantly at the protein level. In this case, constant ligand
stimulation of TAM signaling pathways appear to have sufficient
inhibitory efficacy to interfere with TNF-α gene promoter
activation, whereas not sufficiently to affect levels of cytokine
accumulated in the medium after a time period. In addition,
it was noteworthy that under LPS stimulation conditions, and
contrary to resting cells, knockout of a single TAM receptor
did not decrease expression of the other. Therefore, single TAM
levels were maintained at least at the unstimulated levels and
these cells would be responsive to Gas6 stimulation, which can
explain why Gas6 was also able to inhibit TNF-α expression
in LPS-stimulated Axl−/− cells, as their Mer expression
remains robust.
There are other aspects of the TAM system, receptor
interactions, and their involvement in inflammation touched on
in our work. For example, the distinct responses of Mer and Axl
to inflammatory stimuli suggest potential heterodimerization,
previously proposed when protein S, a Mer and Tyro3 ligand,
was able to stimulate an Axl response (Ray et al., 2017). It
is important to know how the different components interact
before a full understanding of the TAM receptor system is
possible. It is also worth noting that this study focussed solely
on Gas6, a ligand for all three TAM receptors, and not protein
S (Tsou et al., 2014; Al Kafri and Hafizi, 2019) which has also
been purported to have anti-inflammatory functions (Carrera-
Silva et al., 2013; Barth et al., 2018). Furthermore, we have
shown here that Gas6, via the TAM receptors Axl and Mer,
negatively regulates the inflammatory response downstream of
multiple TLRs, and other studies are continuing to elucidate
these interactions (Wu et al., 2018; Herrera-Rivero et al., 2019;
Zahoor et al., 2020). It is vital to probe further to fully clarify
how the TAM system is involved in pro-inflammatory cytokine
mediation and the underlying signaling pathways involved. This
understanding could provide a fresh avenue for the treatment of
many debilitating neuroinflammatory disorders.
In this study, we have used the pro-inflammatory cytokine
TNF-α as a prominent biomarker to investigate proinflammatory
responses (Muhammad, 2019). It is the case however that
microglial responses to inflammation involve the complex release
and functional interplay of many different cytokines (Lively and
Schlichter, 2018). However, our aim here was to gain a clear
view of the role of Gas6 in regulating a major pro-inflammatory
mechanism, and with future work to be directed at investigating
the key signaling pathways and inflammatory markers involved
in the TLR response. Also in this study, analysis of TAM
receptor protein expression may have supplemented the more
sensitive gene expression data; however, the lack of highly
sensitive anti-mouse TAM receptor antibodies coupled with the
low levels of protein present in the samples precluded a reliable
analysis to be done on all the cultures as they were using
qPCR. Furthermore, blockade of Gas6 may have been a useful
tool to allow us to confirm any ligand-dependent roles of the
TAM receptors that occur under basal conditions in microglial
cells. However, currently there are no specific Gas6 ligand traps
available, and therefore it was not possible to completely negate
endogenous Gas6 effects during our experiments. Nevertheless,
our data show the clear modulatory role of Gas6 under
pro-inflammatory conditions, which are the main findings of
this study.
To conclude, we have shown that Gas6, via both TAM
receptors Mer and Axl, has a significant negative regulatory
influence on the pro-inflammatory response in primary mouse
microglia, as observed through TNF-α expression and microglial
morphology, and downstream of multiple TLRs. Furthermore,
pro-inflammatory conditions alter TAM receptor expression
in opposite directions and Axl appears to play a role in the
regulation of Mer expression. These findings have expanded
the current knowledge on the anti-inflammatory capabilities of
Gas6 and TAM receptors in microglia. This new knowledge is
of relevance to a greater understanding of the pathophysiology
of several neurodegenerative diseases as well as potential novel
therapeutic avenues.
DATA AVAILABILITY STATEMENT
The datasets used and/or analyzed during the current study are
available from the corresponding author on reasonable request.
ETHICS STATEMENT
The animal study was reviewed and approved by UK Home
Office project licence (number PC2238199); and University of
Portsmouth ethics committee (AWERB).
AUTHOR CONTRIBUTIONS
SH, SG, and SEG conceived and designed the experiments. SEG
conducted the experiments, analyzed the results, and drafted
the manuscript. SH contributed to data interpretation and
manuscript writing. All authors contributed to the article and
approved the submitted version.
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 October 2020 | Volume 14 | Article 576650
Gilchrist et al. Gas6 Inhibition of Inflammatory Pathways
FUNDING
This research was funded by a project grant from theUKMultiple
Sclerosis (MS) Society (Award no. 60) and through a University
of Portsmouth PhD bursary to SEG.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fncel.2020.5766
50/full#supplementary-material.
REFERENCES
Alciato, F., Sainaghi, P. P., Sola, D., Castello, L., and Avanzi, G. C. (2010). TNF-α,
IL-6 and IL-1 expression is inhibited by GAS6 in monocytes/macrophages.
J. Leukoc. Biol. 87, 869–875. doi: 10.1189/jlb.0909610
Al Kafri, N., and Hafizi, S. (2019). Tumour-secreted protein S (ProS1) activates
a Tyro3-Erk signalling axis and protects cancer cells from apoptosis. Cancers
11:1843. doi: 10.3390/cancers11121843
Amsen, D., de Visser, K. E., and Town, T. (2009). Approaches to determine
expression of inflammatory cytokines. Methods Mol. Biol. 511, 107–142.
doi: 10.1007/978-1-59745-447-6_5
Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., and Donato, R. (2017). The
pathophysiological role of microglia in dynamic surveillance, phagocytosis and
structural remodeling of the developing CNS. Front. Mol. Neurosci. 10:191.
doi: 10.3389/fnmol.2017.00191
Barth, N. D., Marwick, J. A., Heeb,M. H., Gale, A. J., Rossi, A. G., and Dransfield, I.
(2018). Augmentation of human monocyte responses to lipopolysaccharide by
the protein S and Mer/TYRO3 receptor tyrosine kinase axis. J. Immunol. 201,
2602–2611. doi: 10.4049/jimmunol.1800249
Binder, M. D., Cate, H. S., Prieto, A. L., Kemper, D., Butzkueven, H., Gresle, M.M.,
et al. (2008). Gas6 deficiency increases oligodendrocyte loss and microglial
activation in response to cuprizone-induced demyelination. J. Neurosci. 28,
5195–5206. doi: 10.1523/JNEUROSCI.1180-08.2008
Bsibsi, M., Ravid, R., Gveric, D., and Van Noort, J. M. (2002). Broad expression
of toll-like receptors in the human central nervous system. J. Neuropathol. Exp.
Neurol. 61, 1013–1021. doi: 10.1093/jnen/61.11.1013
Camenisch, T. D., Koller, B. H., Earp, H. S., and Matsushima, G. K. (1999).
A novel receptor tyrosine kinase, Mer, inhibits TNF-α production and
lipopolysaccharide-induced endotoxic shock. J. Immunol. 162, 3498–3503.
Carrera-Silva, E. A., Chan, P. Y., Joannas, L., Errasti, A. E., Gagliani, N., Bosurgi, L.,
et al. (2013). T cell-derived protein S engages TAM receptor signaling in
dendritic cells to control the magnitude of the immune response. Immunity
39, 160–170. doi: 10.1016/j.immuni.2013.06.010
Dendrou, C. A., Fugger, L., and Friese, M. A. (2015). Immunopathology of
multiple sclerosis. Nat. Rev. Immunol. 15, 545–558. doi: 10.1038/nri3871
Deng, T., Zhang, Y., Chen, Q., Yan, K., and Han, D. (2011). Toll-like receptor-
mediated inhibition of Gas6 and ProS expression facilitates inflammatory
cytokine production in mouse macrophages. Immunology 135, 40–50.
doi: 10.1111/j.1365-2567.2011.03511.x
Djukic, M., Mildner, A., Schmidt, H., Czesnik, D., Brück, W., Priller, J., et al.
(2006). Circulating monocytes engraft in the brain, differentiate into microglia
and contribute to the pathology following meningitis in mice. Brain 129,
2394–2403. doi: 10.1093/brain/awl206
Fendrick, S. E., Xue, Q.-S., and Streit, W. J. (2007). Formation of multinucleated
giant cells and microglial degeneration in rats expressing a mutant Cu/Zn
superoxide dismutase gene. J. Neuroinflammation 4:9. doi: 10.1186/1742
-2094-4-9
Fourgeaud, L., Través, P. G., Tufail, Y., Leal-Bailey, H., Lew, E. D., Burrola, P. G.,
et al. (2016). TAM receptors regulate multiple features of microglial physiology.
Nature 532, 240–244. doi: 10.1038/nature17630
Frederiksen, H. R., Haukedal, H., and Freude, K. (2019). Cell type specific
expression of toll-like receptors in human brains and implications in
Alzheimer’s disease. Biomed Res. Int. 2019:7420189. doi: 10.1155/2019/
7420189
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H.,
Schmidbauer, M., et al. (2009). The relation between inflammation and
neurodegeneration in multiple sclerosis brains. Brain 132, 1175–1189.
doi: 10.1093/brain/awp070
Gao, T., Jernigan, J., Raza, S. A., Dammer, E. B., Xiao, H., Seyfried, N. T.,
et al. (2019). Transcriptional regulation of homeostatic and disease-
associated-microglial genes by IRF1, LXRβ and CEBPα. Glia 67, 1958–1975.
doi: 10.1002/glia.23678
Goudarzi, S., Gilchrist, S. E., and Hafizi, S. (2020). Gas-6 induces myelination
through anti-inflammatory IL-10 and TGF-β upregulation in white matter and
glia. Cells 9:1779. doi: 10.3390/cells9081779
Grommes, C., Lee, C. Y. D., Wilkinson, B. L., Jiang, Q., Koenigsknecht-
Talboo, J. L., Varnum, B., et al. (2008). Regulation of microglial phagocytosis
and inflammatory gene expression by Gas6 acting on the Axl/Mer family of
tyrosine kinases. J. Neuroimmune Pharmacol. 3, 130–140. doi: 10.1007/s11481-
007-9090-2
Healy, L. M., Perron, G., Won, S.-Y., Michell-Robinson, M. A., Rezk, A.,
Ludwin, S. K., et al. (2016). MerTK is a functional regulator of myelin
phagocytosis by human myeloid cells. J. Immunol. 196, 3375–3384.
doi: 10.4049/jimmunol.1502562
Heneka, M. T., Kummer, M. P., and Latz, E. (2014). Innate immune
activation in neurodegenerative disease. Nat. Rev. Immunol. 14, 463–477.
doi: 10.1038/nri3705
Herrera-Rivero, M., Santarelli, F., Brosseron, F., Kummer, M. P., and
Heneka, M. T. (2019). Dysregulation of TLR5 and TAM ligands in the
Alzheimer’s brain as contributors to disease progression. Mol. Neurobiol. 56,
6539–6550. doi: 10.1007/s12035-019-1540-3
Honjoh, K., Nakajima, H., Hirai, T., Watanabe, S., and Matsumine, A. (2019).
Relationship of inflammatory cytokines fromM1-type microglia/macrophages
at the injured site and lumbar enlargement with neuropathic pain after spinal
cord injury in the CCL21 knockout (plt) mouse. Front. Cell. Neurosci. 13:525.
doi: 10.3389/fncel.2019.00525
Hornik, T. C., Neniskyte, U., and Brown, G. C. (2014). Inflammation induces
multinucleation of microglia via PKC inhibition of cytokinesis, generating
highly phagocytic multinucleated giant cells. J. Neurochem. 128, 650–661.
doi: 10.1111/jnc.12477
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., et al.
(2005). TLR signaling tailors innate immune responses in humanmicroglia and
astrocytes. J. Immunol. 175, 4320–4330. doi: 10.4049/jimmunol.175.7.4320
Ji, R., Tian, S., Lu, H. J., Lu, Q., Zheng, Y., Wang, X., et al. (2013). TAM
receptors affect adult brain neurogenesis by negative regulation of microglial
cell activation. J. Immunol. 191, 6165–6177. doi: 10.4049/jimmunol.1302229
Kalakh, S., and Mouihate, A. (2017). Androstenediol reduces demyelination-
induced axonopathy in the rat corpus callosum: impact on microglial
polarization. Front. Cell. Neurosci. 11:49. doi: 10.3389/fncel.2017.00049
Lee, C.-H., and Chun, T. (2019). Anti-Inflammatory role of TAM family of
receptor tyrosine kinases via modulating macrophage function. Mol. Cells 42,
1–7. doi: 10.14348/molcells.2018.0419
Lemke, G., and Rothlin, C. V. (2008). Immunobiology of the TAM receptors. Nat.
Rev. Immunol. 8, 327–336. doi: 10.1038/nri2303
Li, M., Ye, J., Zhao, G., Hong, G., Hu, X., Cao, K., et al. (2019). Gas6 attenuates
lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells
through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway. Int.
J. Mol. Med. 44, 982–994. doi: 10.3892/ijmm.2019.4275
Lively, S., and Schlichter, L. C. (2018). Microglia responses to pro-inflammatory
stimuli (LPS, IFNγ+TNFα) and reprogramming by resolving cytokines (IL-4,
IL-10). Front. Cell. Neurosci. 12:215. doi: 10.3389/fncel.2018.00215
Lu, Q., and Lemke, G. (2001). Homeostatic regulation of the immune system
by receptor tyrosine kinases of the Tyro3 family. Science 293, 306–311.
doi: 10.1126/science.1061663
Lu, Y.-C., Yeh, W.-C., and Ohashi, P. S. (2008). LPS/TLR4 signal transduction
pathway. Cytokine 42, 145–151. doi: 10.1016/j.cyto.2008.01.006
Mecha, M., Iñigo, P. M., Mestre, L., Hernangomez, M., Borrell, J., and
Guaza, C. (2011). An easy and fast way to obtain a high number of glial
cells from rat cerebral tissue: a beginners approach. Protoc. Exch. 218:1038.
doi: 10.1038/protex.2011.218
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 October 2020 | Volume 14 | Article 576650
Gilchrist et al. Gas6 Inhibition of Inflammatory Pathways
Michell-Robinson, M. A., Touil, H., Healy, L. M., Owen, D. R., Durafourt, B. A.,
Bar-Or, A., et al. (2015). Roles of microglia in brain development,
tissue maintenance and repair. Brain 138, 1138–1159. doi: 10.1093/brain/
awv066
Muhammad, M. (2019). ‘‘Tumour necrosis factor alpha: a major cytokine of
brain neuroinflammation,’’ in Cytokines, ed Payam Benzadi (Rijeka, Croatia:
IntechOpen), 1–14. doi: 10.5772/intechopen.85476
Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells
are highly dynamic surveillants of brain parenchyma in vivo. Science 308,
1314–1319. doi: 10.1126/science.1110647
Olson, J. K., and Miller, S. D. (2004). Microglia initiate central nervous system
innate and adaptive immune responses through multiple TLRs. J. Immunol.
173, 3916–3924. doi: 10.4049/jimmunol.173.6.3916
Prieto, A. L., Weber, J. L., and Lai, C. (2000). Expression of the
receptor protein-tyrosine kinases Tyro-3, Axl and Mer in the
developing rat central nervous system. J. Comp. Neurol. 425, 295–314
doi: 10.1002/10969861(20000918)425:2<295::AID-CNE11>3.0.CO;2-G.
Ray, A. K., DuBois, J. C., Gruber, R. C., Guzik, H.M., Gulinello, M. E., Perumal, G.,
et al. (2017). Loss of Gas6 and Axl signaling results in extensive axonal
damage, motor deficits, prolonged neuroinflammation and less remyelination
following cuprizone exposure. Glia 65, 2051–2069. doi: 10.1002/glia.
23214
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., and Lemke, G. (2007).
TAM receptors are pleiotropic inhibitors of the innate immune response. Cell
131, 1124–1136. doi: 10.1016/j.cell.2007.10.034
Roy, A., Srivastava, M., Saqib, U., Liu, D., Faisal, S. M., Sugathan, S., et al.
(2016). Potential therapeutic targets for inflammation in toll-like receptor
4 (TLR4)-mediated signaling pathways. Int. Immunopharmacol. 40, 79–89.
doi: 10.1016/j.intimp.2016.08.026
Salter, M. W., and Stevens, B. (2017). Microglia emerge as central players in brain
disease. Nat. Med. 23, 1018–1027. doi: 10.1038/nm.4397
Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by
the comparative C(T) method. Nat. Protoc. 3, 1101–1108. doi: 10.1038/nprot.
2008.73
Shafit-Zagardo, B., Gruber, R. C., and DuBois, J. C. (2018). The role of TAM
family receptors and ligands in the nervous system: from development to
pathobiology. Pharmacol. Ther. 188, 97–117. doi: 10.1016/j.pharmthera.2018.
03.002
Song, W. M., and Colonna, M. (2018). The identity and function of microglia in
neurodegeneration. Nat. Immunol. 19, 1048–1058. doi: 10.1038/s41590-018-
0212-1
Stenhoff, J., Dahlbäck, B., and Hafizi, S. (2004). Vitamin K-dependent
Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
Biochem. Biophys. Res. Commun. 319, 871–878. doi: 10.1016/j.bbrc.2004.
05.070
Subedi, L., Lee, J. H., Yumnam, S., Ji, E., and Kim, S. Y. (2019). Anti-
inflammatory effect of sulforaphane on lps-activated microglia potentially
through JNK/AP-1/NF-κB inhibition and Nrf2/HO-1 activation. Cells 8:194.
doi: 10.3390/cells8020194
Tam, W. Y., and Ma, C. H. E. (2014). Bipolar/rod-shaped microglia are
proliferating microglia with distinct M1/M2 phenotypes. Sci. Rep. 4:7279.
doi: 10.1038/srep07279
Tsou, W.-I., Nguyen, K.-Q. N., Calarese, D. A., Garforth, S. J., Antes, A. L.,
Smirnov, S. V., et al. (2014). Receptor tyrosine kinases, TYRO3, AXL and
MER, demonstrate distinct patterns and complex regulation of ligand-induced
activation. J. Biol. Chem. 289, 25750–25763. doi: 10.1074/jbc.M114.569020
Vogel, C., and Marcotte, E. M. (2012). Insights into the regulation of protein
abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13,
227–232. doi: 10.1038/nrg3185
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., et al.
(2001). A subset of NSAIDs lower amyloidogenic Aβ42 independently of
cyclooxygenase activity. Nature 414, 212–216. doi: 10.1038/35102591
Wu, G., McBride, D. W., and Zhang, J. H. (2018). Axl activation attenuates
neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO
in rats. Neurobiol. Dis. 110, 59–67. doi: 10.1016/j.nbd.2017.11.009
Zagórska, A., Través, P. G., Jiménez-García, L., Strickland, J. D., Tapia, F. J.,
Mayoral, R., et al. (2020). Differential TAM receptor regulation of
hepatic physiology and injury. Life Science Alliance 3:e202000694
doi: 10.26508/lsa.202000694
Zagórska, A., Través, P. G., Lew, E. D., Dransfield, I., and Lemke, G. (2014).
Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 15,
920–928. doi: 10.1038/ni.2986
Zahoor, A., Yang, Y., Yang, C., Akhtar, M., Guo, Y., Shukat, A., et al. (2020).
Gas6 negatively regulates the staphylococcus aureus-induced inflammatory
response via TLR signaling in the mouse mammary gland. J. Cell. Physiol. 235,
7081–7093. doi: 10.1002/jcp.29604
Zanier, E. R., Fumagalli, S., Perego, C., Pischiutta, F., and De Simoni, M.-G. (2015).
Shape descriptors of the ‘‘never resting’’ microglia in three different acute brain
injury models in mice. Intensive Care Med. Exp. 3:7. doi: 10.1186/s40635-015-
0039-0
Zhang, B., Wei, Y.-Z., Wang, G.-Q., Li, D.-D., Shi, J.-S., and Zhang, F.
(2019). Targeting MAPK pathways by naringenin modulates microglia
M1/M2 polarization in lipopolysaccharide-stimulated cultures. Front. Cell.
Neurosci. 12:531. doi: 10.3389/fncel.2018.00531
Zhang, X.-M., Lund, H., Mia, S., Parsa, R., and Harris, R. A. (2014). Adoptive
transfer of cytokine-induced immunomodulatory adult microglia attenuates
experimental autoimmune encephalomyelitis in DBA/1mice.Glia 62, 804–817.
doi: 10.1002/glia.22643
Zheng, S., Hedl, M., and Abraham, C. (2015). TAM receptor-dependent
regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine
downregulation following chronic NOD2 stimulation of human macrophages.
J. Immunol. 194, 1928–1937. doi: 10.4049/jimmunol.1401933
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Gilchrist, Goudarzi and Hafizi. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 October 2020 | Volume 14 | Article 576650
